Balanced news tone
News Sentiment
AARTIDRUGS sentiment intelligence
Aarti Drugs Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
60
Balanced news tone
17 relevant articles
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+2.6% over one week, +6.8% over four weeks, trend inactive, and near fair-value range.
Aarti Drugs promoter group encumbers 12.39 lakh shares
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
76/100 classification
One-week reaction
2.6%
Price confirming higher
Trend fit
Trend inactive
6.8% over four weeks
Fair value
-13.2%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
10
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
scanx.trade
Direct company coverage
Aarti Drugs promoter group encumbers 12.39 lakh shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Aarti Drugs to hold analyst meet on June 23 in Tarapur
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Jun 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Aarti Drugs Q4 PAT Rises 36% QoQ to INR55.3 Crores
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Aarti Drugs Limited Just Recorded A 6.8% EPS Beat: Here's What Analysts Are Forecasting Next
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- simplywall.st
scanx.trade
Direct company coverage
Aarti Drugs Limited Receives Credit Rating Reaffirmation from ICRA for Rs. 1,452.80 Crore Facilities
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 24 Mar 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Aarti Drugs Faces Supreme Court Challenge as GST Department Appeals High Court Victory
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Aarti Drugs Sets February 9, 2026 Record Date for ₹2 Interim Dividend
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 03 Feb 2026 08:00
- Source
- scanx.trade
CNBC TV18
Direct company coverage
Aarti Drugs Q3 net profit, revenue up but margins falter; declares ₹2 interim dividend
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 03 Feb 2026 08:00
- Source
- CNBC TV18
scanx.trade
Direct company coverage
Aarti Drugs Limited Schedules Board Meeting for February 3, 2026 to Review Q3FY26 Results and Consider Interim Dividend
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jan 2026 08:00
- Source
- scanx.trade
CNBC TV18
Direct company coverage
Aarti Drugs Ltd. Share Price Today - Aarti Drugs Ltd. Stock Price Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jan 2026 10:51
- Source
- CNBC TV18
simplywall.st
Direct company coverage
Investors Don't See Light At End Of Aarti Drugs Limited's (NSE:AARTIDRUGS) Tunnel And Push Stock Down 25%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Dec 2025 08:00
- Source
- simplywall.st
scanx.trade
Direct company coverage
Aarti Drugs Reports 9% Revenue Growth to ₹653Cr with Improved Margins in Q2FY26
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 07 Nov 2025 08:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Aarti Drugs (NSE:AARTIDRUGS) Has A Pretty Healthy Balance Sheet
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Aug 2025 07:00
- Source
- simplywall.st
Investment Guru India
Direct company coverage
Buy Aarti Drugs Ltd For Target Rs.610 Axis Securities Ltd
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 24 Jul 2025 07:00
- Source
- Investment Guru India
simplywall.st
Direct company coverage
Prakash Patil Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO is the most bullish insider, and their stock value gained 12%last week
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2025 07:00
- Source
- simplywall.st
Moneycontrol.com
Direct company coverage
Q4FY25 earnings impact: Aarti Drugs shares up 14% on profit growth, MGL and KEI shares higher up to 4%
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 07 May 2025 07:00
- Source
- Moneycontrol.com
Value Research
Direct company coverage
Aarti Drugs Ltd. Share Price Today | Aarti Drugs Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2022 11:02
- Source
- Value Research